AngioDynamics (ANGO) Reports In-Line Q2 EPS, Miss on Revenues; Lowers FY18 Revenue Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| AngioDynamics, Inc. (NASDAQ: ANGO) | Delayed: 12.37 +0.01 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.36 | 52 Week High | $17.64 | |||
| Open | $12.37 | 52 Week Low | $9.71 | |||
| Day High | $12.37 | P/E | N/A | |||
| Day Low | $12.37 | EPS | $-0.07 | |||
| Volume | 32,632 | |||||
